Drugs in T2D Flashcards

1
Q

What are the issues in T2D?

A

-Insulin resistance, caused by high levels of Insulin -> no response to it
-Malfunction of insulin receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What does the structure of the insulin receptor look like?

A

Ligand-binding domain (extra-cellular): Cysteine-rich-alpha domain (insulin is a negatively charged acidic protein), and ß-domain

Tyrosine-kinase domain (intra-cellular): INS-R

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What type of interaction is present between the insulin receptor and insulin?

A

Insulin is negatively charged and cysteine is a polar amino acid
-> Ion-Dipol interaction at alpha region of the receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What happens if insulin binds to the receptor?

A

Tyrosine kinase domain (ß-domain): 3 tyrosine residues on the domain are getting autophosphorylated causing downstream signals

-> cellular proteins bind to phosphorylated tyrosine activating a cascade

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the effects of the second messenger cascade?

A

-Insulin sensitivity
-Leptin sensitivity (hunger and satiety signal)
-ß-cell development

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are some drugs related to T2D?

A

-Metformin
-Sulfonyl Ureas (SU)
-Thiazolinedions (TZD)
-DPP-4 inhibitors (DPP4i)
-SGLT-2 inhibitors (SGLT2i)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How is diabetes treated as the disease progresses?

A
  1. Diet and exercise
  2. Monotherapy: Metformin (or other agents)
  3. Dual therapy: Metformin + GLP-1 (or other OADs)
  4. Triple therapy: Metformin + GLP-1 + OADs (or basal insulin)
  5. Combo injectables: Metformin + basal insulin + insulin + GLP-1
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the characteristics of Metformin?

A

-2 attached Guanidies: Biguanide
-originally used to treat viral infections (flu, malaria)
-low blood glucose noted as side effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How do Biguanides work?

A

Not fully understood:
Binds on Adenomonophosphate-Kinase (AMPK)

-AMPK shuts down anabolic processes: Gluconeogenesis

-AMPKS turns ON catabolic processes to use GLUCOSE: Glycolysis, oxidative phosphorylation, ß-oxidation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are examples of Sulfonylurea Drugs and how do they work?

A

Glyburide and Glipizide

-Binding site for SUF on the K+ channel, on the external surface of the cell

-They close K+ channels in the pancreas to depolarize the membrane to open the Ca-channel -> Ca stimulates insulin release

(normally the cell would use Glucose to produce ATP -> ATP would close the K+ channel)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Why are Sulfonylurea Drugs biochemically practical?

A

Because it stimulates the cell to produce insulin without using ATP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Why do Sulfonyl urea drugs don’t always work in T2D patients?

A

Because T2D patients usually have enough insulin already, but it doesn’t work -> still used to treat T2D and see if it improves the patient’s condition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Why do Sulfonyl urea drugs don’t work in T1D patients?

A

Because T1D patients don’t have enough functional ß-cells
-> destroyed by an autoimmune response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How do Thiazolidinediones work?

A

-TZD act on the same receptors as glucocorticoids to utilize GLUCOSE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the role of glucocorticoids like Cortisol?

A

-> Glucocorticoids upregulate glucose when the cell is under stress and needs GLUCOSE
(anti-inflammatory, monitor blood pressure, Na-K electrolyte levels)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the mechanism of Thiazolidinediones?

A

-act on Adipocytes and the liver for energy utilization
-activates Peroxisome proliferator-activated receptor (PPAR) responsible for Glucose uptake (GLUT-4) and lipid utilization and release into the bloodstream

17
Q

Why does it take so long (weeks) to see a response?

A

-act on gene transcription in adipocytes

18
Q

Where is PPAR present?

A

-In the liver and adipocytes -> Fat synthesis
-Muscle cells -> upregulation of Glucose uptake -> increase of insulin sensitivity

19
Q

What is the Glucagon‐like peptide 1 (GLP‐1)?

A

-a peptide hormone produced in the intestinal epithelial cells
-induces an increase of ß-cell mass -> more glucose-stimulated insulin
-inhibits glucagon secretion (glucagon works when glucose is low, produces glucose to get it back to normal)

20
Q

Why can’t we just give human GLP-1 as a therapeutic drug?

A

Because it is metabolized very quickly, it is produced as needed and degraded afterward

To use it as a drug it needs to be altered to last longer

21
Q

How is human GLP-1 altered for therapeutical use?

A

-DPP-4 (another diabetic drug) breaks down GLP-1 by cleaving on Alanin -> Replacement of Alanin -> GLP-1 last longer - EXENATIDE

-Addition of fatty acid to increase the half-life: LIRAGLUTIDE, SEMAGLUTIDE

-Conjugate to anti-body: too big to get excreted in urine: DULAGLUTIDE

-Conjugate to Albumin: circulates longer in the system - ALBIGLUTIDE

22
Q

Why must GLP-1 altered drugs be injected and are not taken orally?

A

Because GLP-1 are peptides, and they would be digested in the small intestine